Stephen E. Weis

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

John R. Downs, Michael Clearfield, Stephen E. Weis et al. · JAMA · 1998 · 5.3K citations

Medicine, Cardiology, Pharmacotherapy +15

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Paul M. Ridker, Nader Rifai, Michael Clearfield et al. · New England Journal of Medicine · 2001 · 1.6K citations · Full text

Medicine, Cardiology, Pharmacology +12

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Timothy R. Sterling, Margarita E. Villarino, Andrey Borisov et al. · New England Journal of Medicine · 2011 · 983 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis

Stephen E. Weis, Philip C. Slocum, Francis X. Blais et al. · New England Journal of Medicine · 1994 · 596 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +14

Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Antonio M. Gotto, Edwin J. Whitney, Evan A. Stein et al. · Circulation · 2000 · 567 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17